DERMABOND HV 0.5ML VIAL - 12EA AHV12

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,other report with the FDA on 2020-03-09 for DERMABOND HV 0.5ML VIAL - 12EA AHV12 manufactured by Ethicon Inc..

Event Text Entries

[186291407] (b)(4). A manufacturing record evaluation was performed for the finished device lot, and no non-conformances were identified. Attempts to obtain the following information have been made and no response to date. If further details or the device are received at a later date a supplemental medwatch will be sent. Are any photos of wound available? Initial wound laceration closure date? Please confirm, it was noted the reaction and dehiscence occurred post op day 5 on (b)(6) 2020? How was the reaction / dehiscence treated (product removed; reoperation; reclosure; prescription steroids; antibiotics prescribed)? If so, please clarify. Please indicate any medical or surgical interventions performed. Please describe how was the adhesive was applied on the tape. What prep was used prior to, during or after dermabond advanced use? Was a dressing placed over the incision? If so, what type of cover dressing used? Is the patient hypersensitive or have allergies to cyanoacrylate or formaldehyde? Is the patient hypersensitive to pressure sensitive adhesives? Were any patch or sensitivity tests performed? Do you have the product lot number involved? What is the physicians opinion of the contributing factors to the reaction? What is the most current patient status? Is the product or representative sample (product from the same lot number) available for evaluation? Patient demographics: initials / id; age or date of birth; bmi; patient pre-existing medical conditions (ie. Allergies, history of reactions). Was prineo/demabond or skin adhesive used on the patient in a previous surgery or wound closure? To date the device has not been returned. If the device or further details are received at a later date a supplemental medwatch will be sent.
Patient Sequence No: 1, Text Type: N, H10


[186291408] It was reported a patient underwent an laceration closure in emergency department on (b)(6) 2020 and topical skin adhesive was used. 5 days later, patient visited resident surgeon to change dressings. Wound dehiscence and massive secretion with vesicles and slight reddening was found. Not typical symptoms for infection. Development of large contact dermatitis. Treatment is still ongoing. Additional information was requested.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2210968-2020-01847
MDR Report Key9808181
Report SourceFOREIGN,OTHER
Date Received2020-03-09
Date of Report2020-02-10
Date of Event2020-01-15
Date Mfgr Received2020-03-10
Device Manufacturer Date2018-11-05
Date Added to Maude2020-03-09
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactKARA DITTY-BOVARD
Manufacturer StreetP.O. BOX 151, ROUTE 22 WEST
Manufacturer CitySOMERVILLE NJ 08876
Manufacturer CountryUS
Manufacturer Postal08876
Manufacturer Phone6107428552
Manufacturer G1ETHICON INC.-SAN LORENZO PR
Manufacturer StreetROAD 183, KM. 8.3
Manufacturer CitySAN LORENZO 00754
Manufacturer Postal Code00754
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameDERMABOND HV 0.5ML VIAL - 12EA
Generic NameADHESIVE, TOPICAL SKIN
Product CodeMPN
Date Received2020-03-09
Catalog NumberAHV12
Lot NumberMMR919
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerETHICON INC.
Manufacturer AddressP.O. BOX 151, ROUTE 22 WEST SOMERVILLE NJ 08876 US 08876


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2020-03-09

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.